Navigation Links
Inadequate Communication Reduces Benefits of Mammogram Screening for Black Women

Black women may not get the full benefits of mammogram screenings because the results are not adequately communicated, according to a new study by //Yale Public Health researchers in the March issue of American Journal of Public Health.

To help reduce death and disability from breast cancer, the second most common cause of cancer death in American women, current guidelines recommend routine mammography screening for women aged 40 years and older. Despite widespread availability of mammography screening and relatively high self-reported screening rates in national survey data, racial disparities persist, in part resulting from diagnosis at later stages in black women when compared to white women.

Beth A. Jones, M.D., associate professor in the Department of Epidemiology and Public Health at Yale School of Medicine led the study. In this community-based, two-year study of black and white women receiving mammograms in Connecticut, the investigators sought possible race-related differences in the screening mammography process.

Jones and colleagues compared self-reported mammogram results, collected by telephone interview, to results listed in the radiology record of 411 black women and 734 white women aged 40 to 79 who underwent screening in five hospital-based facilities in Connecticut. They examined whether black women were as likely as white women to self-report results that matched the mammography radiology report. A second objective was to determine how the results of a screening mammogram affected the communication of those results.

Mammogram screening results were inadequately communicated to or understood by 14.5 percent of all women in the study. Of these, 12.5 percent reported they had not received their screening results, while the other 2.5 percent inaccurately reported their results. Black women were significantly more likely than white women to report never receiving their mammography results and/or to rep
'"/>




Page: 1 2

Related medicine news :

1. Inadequate epilepsy treatment
2. Inadequate Drug Treatment For Youth
3. Inadequate proof to justify routine prostate screen
4. Sterilization Of Dental Instruments Is Inadequate, Says Study
5. Inadequate labeling in sandwiches sold at UK supermarkets
6. Reach Of The Morning-After Pill Treatment Inadequate Among Sexual Assault Victims
7. Training in Australias Medical Schools Inadequate
8. Inadequate Mental Health Fundings, Experts Warn
9. AMA Warns Of Inadequately Trained Doctors Due To Lack of Resources
10. Treatment For ADHD In Kids Inadequate
11. Healthcare Inadequate at Yarl’s Wood Immigration Cente
Post Your Comments:
(Date:9/4/2008)... may be shortchanging their golden years by tappin...iversity of Illinois expert who has studied the fe..., More than three of every four Americans trim th...iming benefits early, a choice many might forego i... consequences, law professor Richard L. Kaplan say...
(Date:9/4/2008)...ncology contract research organization, has publis...uanced Approach to Get Into the Clinic Faster.&quo...al research scientist with 35 years of experience,...mmonly viewed as straightforward investigations ru...rue integration with preclinical, regulatory and c...
(Date:9/4/2008)...NORWICH, England and ONGAR, Ireland,Sept. 4 /PRNe...ofield Media,Europe Ltd, announced on the 29th Aug... publication from Silverdog Publishing., Health a... the iconic,Health and Safety at Work Act 1974 and.... It has been relied upon by blue-chip corporates,...
(Date:9/4/2008)...-FirstCall/ -- ULURU Inc. (Amex:,ULU) today announ...Weisel,Partners Healthcare Conference at 3:15 p.m....out ULURU Inc.:, ULURU Inc. is an emerging specia...ent of a portfolio of wound management, plastic su...nd consumers improved clinical,outcomes through co...
Breaking Medicine News(10 mins):Health News:New guide explores making the most of Social Security 2Health News:New guide explores making the most of Social Security 3Health News:Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development 2Health News:Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development 3Health News:Schofield Publishing Enters the Newsletter Market 2
...c Health suggests that obesity can//increase the r...dy existing. Obesity had been conclusively associa... diabetes, and certain forms of cancer. This is fo...ns have been established between obesity and asthm...
...entists its said that it is better// to go for sur...to wait and see if the disease progresses. Surgery...atectomy, is a common procedure. The researchers h...tectomy done in early stages of prostate cancer be...
... gastro esophageal reflux may be due// to wrong ea.... Nocturnal heartburns often lead to disturbed sle...part from being cause of other disease. Nocturnal ...is often linked with severe form of gastro esophag...
...ce that sheds new light on the details of how Hunt...patient. Huntington's disease is a genetic disorde...o think or move on his own. Early symptoms of the ..., forgetfulness, and inability to concentrate or r...
Other Medicine News:
(Date:9/4/2008)...RNewswire-FirstCall/ -- BioForm Medical,Inc. (Nas...ical study of,Polidocanol, conducted in Germany by...SLER & Co. GmbH (Kreussler), successfully met the ...DA as part of a New Drug Application,(NDA) process...(Efficacy and safety of,Aethoxysklerol compared to...
(Date:9/4/2008)...0 Women at More Than 100 Sites in the U.S., ANN A...ceuticals, a,privately-held biopharmaceutical comp...f compounds to treat endocrine, metabolic and,card...initiated a second,Phase 3 clinical trial of Ophen...-free oral therapy in development for the treatmen...
(Date:9/4/2008)...chedule with Two Abstracts Accepted for Presen...r 2008, BRIDGEWATER, N.J., Sept. 4 /...maceutical company focused on the treatment of,car... the appointment of,Peter L. Garrambone, Jr. to th...,s career includes more than 50 pharmaceutical,tra...
(Date:9/3/2008)... from chronically infected Hepatitis C,patients st...arlier in 2008, - Study is the first to show a s...viral effect of therapeutic Hepatitis C vaccinatio... into a second generation, vaccine formulated wit... activation, VIENNA,...
Breaking Medicine Technology:338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 2338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 3338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 4338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 5QuatRx Initiates Second Phase 3 Study of Ophena(TM) (Ospemifene Tablets) in Women With Postmenopausal Vaginal Syndrome 2QuatRx Initiates Second Phase 3 Study of Ophena(TM) (Ospemifene Tablets) in Women With Postmenopausal Vaginal Syndrome 3Aegerion Pharmaceuticals, Inc. adds Peter Garrambone to Board of Directors, Secures Additional Capital for Clinical Trials 2Favourable Six Months Follow-Up Results From Intercell's Phase II Therapeutic Hepatitis C Program 2Favourable Six Months Follow-Up Results From Intercell's Phase II Therapeutic Hepatitis C Program 3Favourable Six Months Follow-Up Results From Intercell's Phase II Therapeutic Hepatitis C Program 4Millennium Biotechnologies Group Inc 28MBTG OB 29 Announces Appointment of Mark C Mirken as its President and Chief Operating Officer 525 1Millennium Biotechnologies Group Inc 28MBTG OB 29 Announces Appointment of Mark C Mirken as its President and Chief Operating Officer 525 2Millennium Biotechnologies Group Inc 28MBTG OB 29 Announces Appointment of Mark C Mirken as its President and Chief Operating Officer 525 3Tamoxifen Helps Treat Bipolar Disorder 1086 1Tamoxifen Helps Treat Bipolar Disorder 1086 2Tamoxifen Helps Treat Bipolar Disorder 1086 3Putting stem cell research on the fast track 359 1Putting stem cell research on the fast track 359 2Putting stem cell research on the fast track 359 3Putting stem cell research on the fast track 359 4Ken Sperling to Lead CIGNA HealthCare Retiree Solutions Unit 1079 1Ken Sperling to Lead CIGNA HealthCare Retiree Solutions Unit 1079 2
...ESS WIRE)--Apr 12, 2007 - Affymax, Inc.,(Nasdaq:AF...s Phase,2 clinical trial of Hematide(TM) dosed mon... at the National Kidney Foundation (NKF),2007 Spri...ance-switch trial in patients previously treated w...ated that mean,hemoglobin (Hgb) levels can be main...
...The costs of eradicating,poliomyelitis from the re...t term, are much lower than the long term costs of... And a recently developed,monovalent vaccine is al...iomyelitis than an existing trivalent vaccine. The...ne and in an upcoming,issue of The Lancet. , Both ...
Other Medicine Technology:Affymax Announces Results From Phase 2 Clinical Trial of Hematide,for the Treatment of Anemia in Dialysis Patients 2Affymax Announces Results From Phase 2 Clinical Trial of Hematide,for the Treatment of Anemia in Dialysis Patients 3Costs of Eradicating Poliomyelitis Now Are Much Lower Than Trying,to Control It Later 2Costs of Eradicating Poliomyelitis Now Are Much Lower Than Trying,to Control It Later 3
...xpensive of the series. It has the ability to phot... of the cornea. The model comes with a 9 high-reso... of a patients corneal endothelium, you simply ask...rest. The left side of the chin rest allows you to...
The simplest, most accurate Ortho-K lens fitting system ever!
...ogy (oprifocon A) Contact Lenses are rigid gas per...process that temporarily corrects nearsightedness ... and removes them in the morning. During the day, ...y reduced., ,The Euclid Systems Orthokeratology (o...
...ontact lenses used for corneal refractive therapy,...ss (myopia). The patient wears the lenses overnigh...uring the day, nearsightedness is corrected or gre...ct lenses apply slight pressure to the center of t...
Medicine Products: